All Healthcare articles – Page 2
-
White papersChanging dynamics of industrial real estate
Since the end of the Global Financial Crisis (GFC), the industrial sector has been the best-performing core property type, producing robust returns during an extended period of falling vacancy and strong rental growth.
-
Asset Manager NewsPRIMONIAL REIM completes the first stage of the acquisition of Icade’s stake in ICADE SANTÉ for €1.4 billion
Following the exclusivity agreement signed on March 13th, 2023, Primonial REIM is announcing today the closing of the first phase of the acquisition of 64% of Icade’s stake in Icade Santé for €1.4 billion
-
White papersWill AI Transform the Healthcare Industry for Investors?
Healthcare companies are beginning to explore how artificial intelligence (AI) might unlock efficiencies for patients and medical systems. But to transform science fiction into reality, AI applications in the sector must prove that they can improve business profitability to deliver returns for investors.
-
White papersThe power of innovation – From niche to norm
Top 10 interview with Joe Azelby on private markets
-
White papersISA Briefing: Controlling interest: Keeping tabs on residential regulations
Through history, residential rent controls have tended to appear at times of external shock and dislocation.1 COVID-19 and the subsequent inflationary spike have proven to be such a catalyst.
-
White papersLearnings from Earnings: Macro Crosscurrents Make Growth Elusive
Markets are being shaped by disparate trends from falling energy prices to rising interest rates. During first-quarter earnings season, company reports indicated that these crosscurrents are intensifying business challenges—and making it harder for investors to find resilient sources of growth.
-
White papersFrom Healthcare Real Estate To The Well-Being Society: new challenges for Europe
Enabling people to live in good health, and promoting well-being at all ages, are essential conditions for improving the quality of life.
-
White papersGlobal Equity ESG, Annual Report 2022
Read our annual report for an overview of the year just gone, our successful engagements with portfolio companies, and a deep dive on responsible investing in the healthcare sector.
-
White papersHealth equity – Eyeing the greater good, also for investors
Achieving health equity – the state, or goal, of ensuring that everyone has a fair and just opportunity to attain their highest level of health – can deliver benefits for wider society, most notably an increased productive life expectancy.
-
White papersHealthcare-related real estate: attractions and challenges
There has been growing interest among APAC investors in alternative assets, including healthcare-related real estate such as life sciences property and retirement homes, reflecting strong long-run growth prospects in the life sciences industry and demographic trends. We investigate whether healthcare-related real estate sectors will offer significant opportunities for Core and Value-Add investors, or whether they will remain niche markets.
-
White papersEngagement case study: Pfizer
Pfizer, in response to investor feedback, published its “Industry associations – Report on incongruencies” which provides greater transparency into how its public policy positions are aligned with the trade associations of which it is a member.
-
White papersRedefining Offense and Defense in Equities: The Evolution of Technology and Healthcare
Investors tend to have deeply engrained beliefs about what performs best in various market conditions—often for good reason. But sometimes, common knowledge becomes obsolete. Technology and healthcare are good examples of sectors that can play different equity-allocation roles than you might expect.
- Previous Page
- Page1
- Page2
- Next Page
